Biota Gets U.S. Shareholders, Listing, Cash in Nabi Merger
By Trista Morrison
Wednesday, April 25, 2012
After more than a year of evaluating ways to access U.S. shareholders, Aussie biotech Biota Holdings Ltd. settled on a merger with Nabi Biopharmaceuticals Inc.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.